As a global enterprise, InBody’s buyers are located in over 60 countries ar ound
the world. Over 50% of the total revenue is generated from exports. In addition
to InBody Co., Ltd, which serves as the head office of operations, subsidiaries
are present in USA, China, and Japan. It takes priority in keeping a close and healthy
relationship with its agents worldwide.
The first overseas subsidiary, InBody, Inc., is facing a steady growth of business
in the medical and fitness markets every year. The structure and system of InBody,
Co., Ltd., was completely transformed to assimilate to the American market. All
sales representatives must pass a series of tests in a 30 day window and must receive
certification to be considered an ‘InBody Specialist’. Having successfully executed
various sales-related projects, InBody, Inc. is actively exploring opportunities
of expansion into larger markets, i.e. the public sector, while maintaining its
leadership position in the current market.
InBody Japan Inc., established around the same time as InBody, Inc. has its headquarters
in Tokyo with branch offices in Osaka, Gifu, Hiroshima, and Kyushu. Works are underway
to create independence from the Tokyo office, so each of these offices can function
as independent subsidiaries. Technological excellence of the InBody is receiving
enormous recognition throughout Japan, with a significant number of published research
papers in medical journals involving the use of InBody. With accumulation of studies
based on the InBody use, InBody Japan boasts a wealth of clinical data unequal to
any other subsidiary; thus serving as a platform for market expansion.
Established in 2008, InBody China has main office in Shanghai, with subsidiaries
throughout Beijing, Guangzhou, and Chengdu. Despite being in the early stages of
understanding the importance of body composition analysis, at present time, InBody
China is reaching out to uncharted waters; and it is already boasting a business
market scale larger than any other InBody subsidiary. InBody China is currently
focusing on the medical and sport markets while continuing its participation in
various government projects. The market to be explored in China is expected to see
a continuous long term growth as it is significantly large in both size and potential.
In the subsidiary-centered, global network of InBody, the regional managers are
continuously participating in exhibitions, and academic activities, to share the
latest information in marketing as well as technology; in order to expand growth
in the global market even further.